The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Geloplasma, Solution for Infusion

3 gram(s) Solution for infusion

Fresenius Kabi Deutschland GmbHPA2059/008/001

Main Information

Trade NameGeloplasma, Solution for Infusion
Active SubstancesModified liquid gelatine
Sodium chloride
Magnesium chloride hexahydrate
Potassium chloride
Sodium lactate solution
Strength3 gram(s)
Dosage FormSolution for infusion
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberPA2059/008/001

Group Information

ATC CodeB05AA Blood substitutes and plasma protein fractions


Licence Issued20/04/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back